| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 01/26/1994 | EP0382841B1 Wound healing |
| 01/26/1994 | CN1081184A Erythromycin derivatives |
| 01/26/1994 | CN1081182A New substituted phenylimidazolidines, their preparation process, their use as medicaments and the pharmaceutical compositions containing them |
| 01/26/1994 | CN1023602C Antipsychotic 3-piperazinylbenzazole derivants |
| 01/25/1994 | US5281717 Pharmaceuticals |
| 01/25/1994 | US5281702 Di-N-deacetyl-lysogangliosides |
| 01/25/1994 | US5281627 Guanidine substituted arginines |
| 01/25/1994 | US5281623 Method for treating inflammation |
| 01/25/1994 | US5281615 Hypotensive agents |
| 01/25/1994 | US5281613 Heterocyclic ring substituted benzofuran, benzothiofuran, or indole derivative |
| 01/25/1994 | US5281598 Piperazine derivatives |
| 01/25/1994 | CA1326483C (aza) naphtalesultame derivatives, processes for their preparation and medicines containing them |
| 01/25/1994 | CA1326460C Regulation of cell proliferation and differentiation using peptides |
| 01/25/1994 | CA1326441C Pharmaceutical compositions with anti-cancer activity and method for the treatment of cancer |
| 01/24/1994 | CA2100640A1 Substitute benzoate derivatives |
| 01/23/1994 | CA2100927A1 Benzimidazoles, pharmaceutical compositions containing these compounds and processes for preparing them |
| 01/21/1994 | CA2100610A1 Monensin derivatives |
| 01/20/1994 | WO1994001556A1 Polypeptides having serotoninergic receptor activity (5ht6), nucleic acids coding for said polypeptides, and uses thereof |
| 01/20/1994 | WO1994001555A1 Polypeptides having serotoninergique activity (5ht5a), nucleic acids coding for these polypeptides and uses thereof |
| 01/20/1994 | WO1994001547A2 A method for generation of antibodies to cell surface molecules |
| 01/20/1994 | WO1994001460A1 Analogs of pth and pthrp, their synthesis and use for the treatment of osteoporosis |
| 01/20/1994 | WO1994001455A1 Fluorine comprising dipeptides as inhibitors against human leucocyte elastase inhibitors |
| 01/20/1994 | WO1994001437A1 Novel 4-(3-benzofuranyl)piperidinyl and 4-(3-benzothienyl)piperidinyl derivatives and pharmaceutical compositions containing them |
| 01/20/1994 | WO1994001430A1 2,5-diaryl tetrahydro-thiophenes, -furans and analogs for the treatment of inflammatory and immune disorders |
| 01/20/1994 | WO1994001421A1 Benzothiazepine and benzoxazepine derivatives as cholecystokinin receptor antagonists |
| 01/20/1994 | WO1994001414A1 Uracil derivatives as enzyme inhibitors |
| 01/20/1994 | WO1994001412A1 1-arylsulphonyl, arylcarbonyl and 1-arylphosphonyl-3-phenyl-1,4,5,6-tetrahydropyridazines |
| 01/20/1994 | WO1994001406A1 Contrast agents for mr diagnosis |
| 01/20/1994 | WO1994001398A1 Vitamin d analogues |
| 01/20/1994 | WO1994001139A1 Targeting somatic gene therapy to joints |
| 01/20/1994 | WO1994001127A1 Lysozyme dimer and compositions containing the same |
| 01/20/1994 | WO1994001102A1 Aminimide-containing molecules and materials as molecular recognition agents |
| 01/20/1994 | WO1994001099A1 Pharmaceutical composition having anti-alcohol, radioprotecting and anti-choleraic activity and stimulating energy metabolism, stomach mucous membrane acid-generation and secretion functions |
| 01/20/1994 | CA2140140A1 Lysozyme dimer and compositions containing the same |
| 01/20/1994 | CA2140034A1 2,5-diaryl tetrahydro-thiophenes, -furans and analogs for the treatment of inflammatory and immune disorders |
| 01/20/1994 | CA2139836A1 Iracil derivatives as enzyme inhibitors |
| 01/20/1994 | CA2139431A1 Polypeptides having serotoninergie activity (5ht6), nucleic acids coding for said polypeptides, and uses thereof |
| 01/20/1994 | CA2139421A1 Fluorine comprising dipeptides as inhibitors against human leucocyte elastase inhibitors |
| 01/20/1994 | CA2139417A1 Benzothiazepine and benzoxazepine derivatives |
| 01/20/1994 | CA2139349A1 Aminimide-containing molecules and materials as molecular recognition agents |
| 01/20/1994 | CA2139307A1 1-arylsulphonyl, arylcarbonyl and 1-arylphosphonyl-3-phenyl-1,4,5,6-tetrahydropyridazines |
| 01/20/1994 | CA2131631A1 Vitamin d analogues |
| 01/19/1994 | EP0579507A1 Isoxazole derivatives for the treatment of irritable bowel syndrome |
| 01/19/1994 | EP0579496A1 4-Aminoquinazoline derivatives, and their use as medicine |
| 01/19/1994 | EP0579412A1 1,2,4-trioxygenated benzene derivatives useful as a leukotriene antagonists |
| 01/19/1994 | EP0579333A2 Antibacterial antiplaque oral composition |
| 01/19/1994 | EP0579304A1 Heteroarylnaphthalenes as inhibitors of leukotriene biosynthesis |
| 01/19/1994 | EP0579066A2 N-substituted anilines |
| 01/19/1994 | EP0578978A1 Dipeptide derivative and prophylactic or therapeutic agent for bone diseases containing same as active ingredient |
| 01/19/1994 | EP0578965A1 Compositions and methods for treating gastrointestinal disorders |
| 01/19/1994 | EP0578790A1 Synthetic alpha-l-iduronidase and genetic sequences encoding same |
| 01/19/1994 | CN1080959A Recombinant stimulating factor of the neu receptor |
| 01/19/1994 | CN1080931A Calcium channel blocking polypeptides from filistata hibernalis |
| 01/19/1994 | CN1080923A Sulfonylbenzyl-substituted benzo-and pyridopyridones |
| 01/19/1994 | CN1080916A Tachiquinine antagonist tricyclic compounds, preparation of same and pharmaceutical compositions containing such compounds |
| 01/19/1994 | CN1080852A Dosage aerosols containing the active substance flezelastin and related structures |
| 01/19/1994 | CN1080851A Agent for increasing somatostatin or for inhibiting decrease of somato statin |
| 01/18/1994 | US5280125 Chemical process for the preparation of 3-alkylated indole |
| 01/18/1994 | US5280106 Pentapeptide; collagenase inhibitor |
| 01/18/1994 | US5280039 Containing indole and benzene ring structure |
| 01/18/1994 | US5280033 Substituted 1-(alkoxy-iminoalkyl) imidazole derivatives and their use in treating disease related to an enhancement of thromboxane-A2 syntheis |
| 01/18/1994 | US5280016 Inhibitor of smooth muscle cell proliferation at low concentration |
| 01/18/1994 | US5279835 Compression molding with water soluble material such as sorbitol, mannitol and sodium chloride |
| 01/18/1994 | CA2100399A1 Isoxazole derivatives for the treatment of irritable bowel syndrome |
| 01/16/1994 | CA2100626A1 4-aminoquinazoline derivatives |
| 01/16/1994 | CA2099294A1 N-substituted anilines |
| 01/12/1994 | EP0578620A1 Pharmaceutical compositions for transdermal delivery of melatonin and/or its analogues |
| 01/12/1994 | EP0578511A1 Spirooxathiolane-quinuclidine derivative, for treating Sjoegren syndrome |
| 01/12/1994 | EP0578278A1 Uses of IL-1 alpha |
| 01/12/1994 | EP0578231A1 Inclusion complexes of clavulanic acid and of alkali salts thereof with beta-cyclodextrines |
| 01/12/1994 | EP0578083A2 Cyclic adhesion inhibitors |
| 01/12/1994 | EP0578077A2 Compositions containing retinoic acids and tocopherol |
| 01/12/1994 | EP0578002A1 Imidazolyl substituted phenylpropionic and cinnamic acid derivatives |
| 01/12/1994 | EP0577957A1 8-Chloro-11-[1-[(5-methyl-3-pyridyl)methyl]-4-piperidyliden]-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine |
| 01/12/1994 | EP0577847A1 Morphinan derivative and medicinal use |
| 01/12/1994 | EP0577756A1 New non-anticoagulant heparin derivatives |
| 01/12/1994 | EP0577725A1 Targeted drug delivery via mixed phosphate derivatives |
| 01/12/1994 | EP0577716A1 New non-anticoagulant heparin derivatives |
| 01/12/1994 | EP0577605A1 G protein-coupled glutamate receptors |
| 01/12/1994 | EP0463101B1 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations |
| 01/12/1994 | EP0382716B1 Use of commercial lecithin as skin penetration enhancer |
| 01/12/1994 | EP0287652B1 Serum-free medium for the proliferation of lymphokine-activated killer cells |
| 01/12/1994 | CN1080634A Cyclopentane-and-pentene-b-amino acids |
| 01/12/1994 | CN1080525A Pharmaceutical compositions |
| 01/12/1994 | CN1023485C Substituted silyl alkylene amines |
| 01/11/1994 | US5278332 Ethers of myoinsitol phosphate for drugs or foods |
| 01/11/1994 | US5278296 Production of hydroxysteryl glycoside compounds |
| 01/11/1994 | US5278185 Piperidine, Tetrahydropyridine and pyrrolidine compounds |
| 01/11/1994 | US5278162 Learning enhancement |
| 01/11/1994 | US5278150 Vasodilation |
| 01/11/1994 | US5277907 Regulation of the immune system |
| 01/11/1994 | CA2098550A1 Compositions containing retinoic acids and tocopherol |
| 01/11/1994 | CA1326034C Thiazole derivative and leukotriene antagonist containing the same as the effective ingredients |
| 01/11/1994 | CA1326033C Pyrrolidineamide derivative having anti-prolyl endopeptidase activity |
| 01/11/1994 | CA1326030C Cyclohept[b]indolealkanoic acids |
| 01/11/1994 | CA1326029C 4-thiazolidine-carboxylic acid derivative, its preparation and pharmaceutical compositions containing it |
| 01/11/1994 | CA1326022C 6-oxoprostaglandin-e derivatives, method for their manufacture and their use as pharmaceuticals |
| 01/09/1994 | CA2100045A1 Inclusion complexes of clavulanic acid and of alkali salts thereof with hydrophilic and hydrophobic .beta. - cyclodextrin derivatives, a proce ss for the preparation thereof and the use thereof |
| 01/09/1994 | CA2097248A1 Substituted phenylimidazolidines, a process for their preparation, their application as medicaments and pharmaceutical compositions containing them |
| 01/06/1994 | WO1994000485A1 Multimeric forms of human rhinovirus receptor protein |